Rhythm Pharmaceuticals (RYTM) Free Cash Flow (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Free Cash Flow of -$43.8 million for Q1 2026, down 8.7% year-over-year from -$47.9 million in Q1 2025, and down 67.82% quarter-over-quarter from -$26.1 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Free Cash Flow (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Free Cash Flow for 11 consecutive years, with -$43.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow fell 8.7% year-over-year to -$43.8 million; the TTM figure through Mar 2026 stood at -$119.6 million (down 4.36% YoY), while the FY2025 annual figure was -$116.1 million, down 1.93% from the prior year.
- Free Cash Flow fell to -$43.8 million in Q1 2026 per RYTM's latest filing, from -$26.1 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$17.9 million in Q2 2025 and bottomed at -$53.8 million in Q1 2022.
- Historically, Free Cash Flow has averaged -$34.2 million across 5 years, with a median of -$31.9 million in 2025.
- Annual changes were most pronounced in 2022 — Free Cash Flow plunged 60.27% — and 2023, when it jumped 44.4%.
- Rhythm Pharmaceuticals' Free Cash Flow stood at -$29.4 million in 2022, then grew by 0.18% to -$29.4 million in 2023, then advanced by 25.13% to -$22.0 million in 2024, then dropped by 18.49% to -$26.1 million in 2025, then slumped by 67.82% to -$43.8 million in 2026.
- Business Quant data shows RYTM's Free Cash Flow at -$43.8 million in Q1 2026, -$26.1 million in Q4 2025, and -$31.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | -9.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.15 Mn |
| Jun 30, 2026 | -9.15 Mn |
| Mar 31, 2026 | -43.75 Mn |
| Mar 31, 2026 | -43.75 Mn |
| Dec 31, 2025 | -26.07 Mn |
| Dec 31, 2025 | -26.07 Mn |
| Sep 30, 2025 | -31.86 Mn |
| Sep 30, 2025 | -31.86 Mn |
| Jun 30, 2025 | -17.89 Mn |
| Jun 30, 2025 | -17.89 Mn |
| Mar 31, 2025 | -40.25 Mn |
| Mar 31, 2025 | -40.25 Mn |
| Dec 31, 2024 | -22.00 Mn |
| Dec 31, 2024 | -22.00 Mn |
| Sep 30, 2024 | -24.31 Mn |
| Sep 30, 2024 | -24.31 Mn |
| Jun 30, 2024 | -28.02 Mn |
| Jun 30, 2024 | -28.02 Mn |
| Mar 31, 2024 | -39.55 Mn |
| Mar 31, 2024 | -39.55 Mn |